These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 11563998)

  • 1. Comparable clinical efficacy and tolerability of 20 mg pantoprazole and 20 mg omeprazole in patients with grade I reflux oesophagitis.
    Bardhan KD; Van Rensburg C
    Aliment Pharmacol Ther; 2001 Oct; 15(10):1585-91. PubMed ID: 11563998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pantoprazole and omeprazole in the treatment of reflux oesophagitis: a European multicentre study.
    Corinaldesi R; Valentini M; Belaïche J; Colin R; Geldof H; Maier C
    Aliment Pharmacol Ther; 1995 Dec; 9(6):667-71. PubMed ID: 8824655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparable efficacy of pantoprazole and omeprazole in patients with moderate to severe reflux esophagitis. Results of a multinational study.
    Körner T; Schütze K; van Leendert RJ; Fumagalli I; Costa Neves B; Bohuschke M; Gatz G
    Digestion; 2003; 67(1-2):6-13. PubMed ID: 12743434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pantoprazole 20 mg is effective for relief of symptoms and healing of lesions in mild reflux oesophagitis.
    Dettmer A; Vogt R; Sielaff F; Lühmann R; Schneider A; Fischer R
    Aliment Pharmacol Ther; 1998 Sep; 12(9):865-72. PubMed ID: 9768529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pantoprazole versus lansoprazole in French patients with reflux esophagitis.
    Dupas JL; Houcke P; Samoyeau R;
    Gastroenterol Clin Biol; 2001 Mar; 25(3):245-50. PubMed ID: 11395670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical superiority of pantoprazole over ranitidine in the treatment of reflux esophagitis grade II and III. A prospective, double-blind, double-placebo study. Mexican clinical experience. Mexican Pantoprazole Study Group].
    Gallo S; Dibildox M; Moguel A; Di Silvio M; Rodríguez F; Almaguer I; García C
    Rev Gastroenterol Mex; 1998; 63(1):11-6. PubMed ID: 10068743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the efficacy of pantoprazole vs. nizatidine in the treatment of erosive oesophagitis: a randomized, active-controlled, double-blind study.
    Kovacs TO; Wilcox CM; DeVault K; Miska D; Bochenek W;
    Aliment Pharmacol Ther; 2002 Dec; 16(12):2043-52. PubMed ID: 12452936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of omeprazole, lansoprazole and pantoprazole in the maintenance treatment of severe reflux oesophagitis.
    Jaspersen D; Diehl KL; Schoeppner H; Geyer P; Martens E
    Aliment Pharmacol Ther; 1998 Jan; 12(1):49-52. PubMed ID: 9692700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. One-year prophylactic efficacy and safety of pantoprazole in controlling gastro-oesophageal reflux symptoms in patients with healed reflux oesophagitis.
    Mössner J; Koop H; Porst H; Wübbolding H; Schneider A; Maier C
    Aliment Pharmacol Ther; 1997 Dec; 11(6):1087-92. PubMed ID: 9663834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and tolerability of 20 mg pantoprazole versus 300 mg ranitidine in patients with mild reflux-oesophagitis: a randomized, double-blind, parallel, and multicentre study.
    van Zyl JH; de K Grundling H; van Rensburg CJ; Retief FJ; O'Keefe SJ; Theron I; Fischer R; Bethke T
    Eur J Gastroenterol Hepatol; 2000 Feb; 12(2):197-202. PubMed ID: 10741935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double-blind, randomized comparison of omeprazole Multiple Unit Pellet System (MUPS) 20 mg, lansoprazole 30 mg and pantoprazole 40 mg in symptomatic reflux oesophagitis followed by 3 months of omeprazole MUPS maintenance treatment: a Dutch multicentre trial.
    Mulder CJ; Westerveld BD; Smit JM; Oudkerk Pool M; Otten MH; Tan TG; van Milligen de Wit AW; de Groot GH;
    Eur J Gastroenterol Hepatol; 2002 Jun; 14(6):649-56. PubMed ID: 12072599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and tolerability of pantoprazole 40 mg versus 80 mg in patients with reflux oesophagitis.
    van Rensburg CJ; Honiball PJ; Grundling HD; van Zyl JH; Spies SK; Eloff FP; Simjee AE; Segal I; Botha JF; Cariem AK; Marks IN; Theron I; Bethke TD
    Aliment Pharmacol Ther; 1996 Jun; 10(3):397-401. PubMed ID: 8791969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pantoprazole versus omeprazole in the treatment of reflux esophagitis.
    Vcev A; Stimac D; Vceva A; Takac B; Ivandić A; Pezerović D; Horvat D; Nedić P; Kotromanović Z; Maksimović Z; Vranjes Z; Males J; Jurisić-Orzen D; Vladika I; Stimac T; Mandić B
    Acta Med Croatica; 1999; 53(2):79-82. PubMed ID: 10705625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A double-blind study of pantoprazole and omeprazole in the treatment of reflux oesophagitis: a multicentre trial.
    Mössner J; Hölscher AH; Herz R; Schneider A
    Aliment Pharmacol Ther; 1995 Jun; 9(3):321-6. PubMed ID: 7654895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of oral pantoprazole 20 mg given once daily for reflux esophagitis in children.
    Madrazo-de la Garza A; Dibildox M; Vargas A; Delgado J; Gonzalez J; Yañez P
    J Pediatr Gastroenterol Nutr; 2003 Feb; 36(2):261-5. PubMed ID: 12548064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relapse prevention in reflux oesophagitis with regard to Helicobacter pylori status: a double-blind, randomized, multicentre trial to compare the efficacy of pantoprazole versus ranitidine.
    Adamek RJ; Behrendt J; Wenzel C
    Eur J Gastroenterol Hepatol; 2001 Jul; 13(7):811-7. PubMed ID: 11474311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pantoprazole. A review of its pharmacological properties and therapeutic use in acid-related disorders.
    Fitton A; Wiseman L
    Drugs; 1996 Mar; 51(3):460-82. PubMed ID: 8882382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral pantoprazole for erosive esophagitis: a placebo-controlled, randomized clinical trial. Pantoprazole US GERD Study Group.
    Richter JE; Bochenek W
    Am J Gastroenterol; 2000 Nov; 95(11):3071-80. PubMed ID: 11095320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of erosive oesophagitis relapse with pantoprazole.
    Richter JE; Fraga P; Mack M; Sabesin SM; Bochenek W;
    Aliment Pharmacol Ther; 2004 Sep; 20(5):567-75. PubMed ID: 15339328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maintenance therapy with pantoprazole 20 mg prevents relapse of reflux oesophagitis.
    Escourrou J; Deprez P; Saggioro A; Geldof H; Fischer R; Maier C
    Aliment Pharmacol Ther; 1999 Nov; 13(11):1481-91. PubMed ID: 10571605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.